Falcon Finance vs Mira — how do they compare? Falcon Finance trades at Rp1,144 (market cap Rp3,5T, Rp95,63M 24h volume), while Mira trades at Rp700.16 (market cap Rp226,43M, Rp101,47M 24h volume). The key difference: Falcon Finance is far larger — about 15457.3× Mira's market cap, and Falcon Finance's circulating supply is 3,1B / 10B FF (31%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Falcon Finance for 8 Days and Mira for 22 Days on average.
| FF | MIRA | |
|---|---|---|
Market Cap | Rp3,5T | Rp226,43M |
Volume (24h) | Rp95,63M | Rp101,47M |
Circulating Supply | 3,1B / 10B FF (31%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 8 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
Falcon Finance (FF) is trading at Rp1,153.87 with a market cap of Rp3.53T, showing a neutral technical signal overall. The asset is in a consolidation phase, with key support at Rp1,136 and resistance at Rp1,180. With a circulating supply of 3.1M tokens (31% of max supply) and an average hold time of 8 days, on-chain activity indicates moderate distribution. Recent news lacks specific crypto ecosystem updates, focusing instead on unrelated corporate entities, suggesting limited fundamental catalysts for the token itself.
The outlook for FF is neutral with a cautious bias. The primary opportunity lies in a breakout above Rp1,180, which could target higher resistances. Major risks include low fundamental development activity, potential liquidity constraints from the limited circulating supply, and high volatility typical of smaller-cap crypto assets. Investors should monitor for genuine protocol updates or exchange listings to confirm momentum.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
Falcon Finance is developing a universal collateral infrastructure that transforms any liquid asset—such as digital assets, currency-backed tokens, and tokenized real-world assets—into USD-pegged on-chain liquidity. The native token of the protocol, FF, serves as a gateway to governance, staking rewards, community incentives, and exclusive access to unique products and features.
Read more on FF →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →